New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA.

Benedict, C R

New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA. [electronic resource] - Circulation Nov 1995 - 3032-40 p. digital

Publication Type: Comparative Study; Journal Article

0009-7322

10.1161/01.cir.92.10.3032 doi


Animals
Carotid Artery Thrombosis--drug therapy
Fibrinolytic Agents--adverse effects
Hemorrhage--chemically induced
Humans
Kringles
Male
Molecular Sequence Data
Platelet Aggregation--drug effects
Rabbits
Tissue Plasminogen Activator--adverse effects